Copyright Reports & Markets. All rights reserved.

Global Drug Coated Stent System Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Drug Coated Stent System Consumption Value by Type: 2020 Versus 2024 Versus 2031
    • 1.3.2 Rapamycin Coated Stent
    • 1.3.3 Ivimox Coated Bracket
    • 1.3.4 Paclitaxel Coated Stent
    • 1.3.5 Zothamos Coated Bracket
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Drug Coated Stent System Consumption Value by Application: 2020 Versus 2024 Versus 2031
    • 1.4.2 Hospital
    • 1.4.3 Clinic
    • 1.4.4 Others
  • 1.5 Global Drug Coated Stent System Market Size & Forecast
    • 1.5.1 Global Drug Coated Stent System Consumption Value (2020 & 2024 & 2031)
    • 1.5.2 Global Drug Coated Stent System Sales Quantity (2020-2031)
    • 1.5.3 Global Drug Coated Stent System Average Price (2020-2031)

2 Manufacturers Profiles

  • 2.1 QualiMe
    • 2.1.1 QualiMe Details
    • 2.1.2 QualiMe Major Business
    • 2.1.3 QualiMe Drug Coated Stent System Product and Services
    • 2.1.4 QualiMe Drug Coated Stent System Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.1.5 QualiMe Recent Developments/Updates
  • 2.2 Medtronic
    • 2.2.1 Medtronic Details
    • 2.2.2 Medtronic Major Business
    • 2.2.3 Medtronic Drug Coated Stent System Product and Services
    • 2.2.4 Medtronic Drug Coated Stent System Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.2.5 Medtronic Recent Developments/Updates
  • 2.3 Cardionovum
    • 2.3.1 Cardionovum Details
    • 2.3.2 Cardionovum Major Business
    • 2.3.3 Cardionovum Drug Coated Stent System Product and Services
    • 2.3.4 Cardionovum Drug Coated Stent System Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.3.5 Cardionovum Recent Developments/Updates
  • 2.4 MicroPort
    • 2.4.1 MicroPort Details
    • 2.4.2 MicroPort Major Business
    • 2.4.3 MicroPort Drug Coated Stent System Product and Services
    • 2.4.4 MicroPort Drug Coated Stent System Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.4.5 MicroPort Recent Developments/Updates
  • 2.5 P+F Products + Features GmbH
    • 2.5.1 P+F Products + Features GmbH Details
    • 2.5.2 P+F Products + Features GmbH Major Business
    • 2.5.3 P+F Products + Features GmbH Drug Coated Stent System Product and Services
    • 2.5.4 P+F Products + Features GmbH Drug Coated Stent System Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.5.5 P+F Products + Features GmbH Recent Developments/Updates
  • 2.6 Boston Scientific
    • 2.6.1 Boston Scientific Details
    • 2.6.2 Boston Scientific Major Business
    • 2.6.3 Boston Scientific Drug Coated Stent System Product and Services
    • 2.6.4 Boston Scientific Drug Coated Stent System Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.6.5 Boston Scientific Recent Developments/Updates
  • 2.7 Abbott
    • 2.7.1 Abbott Details
    • 2.7.2 Abbott Major Business
    • 2.7.3 Abbott Drug Coated Stent System Product and Services
    • 2.7.4 Abbott Drug Coated Stent System Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.7.5 Abbott Recent Developments/Updates
  • 2.8 Biotronik
    • 2.8.1 Biotronik Details
    • 2.8.2 Biotronik Major Business
    • 2.8.3 Biotronik Drug Coated Stent System Product and Services
    • 2.8.4 Biotronik Drug Coated Stent System Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.8.5 Biotronik Recent Developments/Updates
  • 2.9 USM Healthcare
    • 2.9.1 USM Healthcare Details
    • 2.9.2 USM Healthcare Major Business
    • 2.9.3 USM Healthcare Drug Coated Stent System Product and Services
    • 2.9.4 USM Healthcare Drug Coated Stent System Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.9.5 USM Healthcare Recent Developments/Updates
  • 2.10 Concept Medical Inc
    • 2.10.1 Concept Medical Inc Details
    • 2.10.2 Concept Medical Inc Major Business
    • 2.10.3 Concept Medical Inc Drug Coated Stent System Product and Services
    • 2.10.4 Concept Medical Inc Drug Coated Stent System Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.10.5 Concept Medical Inc Recent Developments/Updates
  • 2.11 MicroPort Scientific Corporation
    • 2.11.1 MicroPort Scientific Corporation Details
    • 2.11.2 MicroPort Scientific Corporation Major Business
    • 2.11.3 MicroPort Scientific Corporation Drug Coated Stent System Product and Services
    • 2.11.4 MicroPort Scientific Corporation Drug Coated Stent System Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.11.5 MicroPort Scientific Corporation Recent Developments/Updates
  • 2.12 Lepu Medical Technology
    • 2.12.1 Lepu Medical Technology Details
    • 2.12.2 Lepu Medical Technology Major Business
    • 2.12.3 Lepu Medical Technology Drug Coated Stent System Product and Services
    • 2.12.4 Lepu Medical Technology Drug Coated Stent System Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.12.5 Lepu Medical Technology Recent Developments/Updates
  • 2.13 JW Medical Systems
    • 2.13.1 JW Medical Systems Details
    • 2.13.2 JW Medical Systems Major Business
    • 2.13.3 JW Medical Systems Drug Coated Stent System Product and Services
    • 2.13.4 JW Medical Systems Drug Coated Stent System Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.13.5 JW Medical Systems Recent Developments/Updates
  • 2.14 SINOMED
    • 2.14.1 SINOMED Details
    • 2.14.2 SINOMED Major Business
    • 2.14.3 SINOMED Drug Coated Stent System Product and Services
    • 2.14.4 SINOMED Drug Coated Stent System Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.14.5 SINOMED Recent Developments/Updates
  • 2.15 Kinhely Bio-Tech
    • 2.15.1 Kinhely Bio-Tech Details
    • 2.15.2 Kinhely Bio-Tech Major Business
    • 2.15.3 Kinhely Bio-Tech Drug Coated Stent System Product and Services
    • 2.15.4 Kinhely Bio-Tech Drug Coated Stent System Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.15.5 Kinhely Bio-Tech Recent Developments/Updates
  • 2.16 Shandong Huaan Biotechnology
    • 2.16.1 Shandong Huaan Biotechnology Details
    • 2.16.2 Shandong Huaan Biotechnology Major Business
    • 2.16.3 Shandong Huaan Biotechnology Drug Coated Stent System Product and Services
    • 2.16.4 Shandong Huaan Biotechnology Drug Coated Stent System Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.16.5 Shandong Huaan Biotechnology Recent Developments/Updates
  • 2.17 Blue Sail Medical
    • 2.17.1 Blue Sail Medical Details
    • 2.17.2 Blue Sail Medical Major Business
    • 2.17.3 Blue Sail Medical Drug Coated Stent System Product and Services
    • 2.17.4 Blue Sail Medical Drug Coated Stent System Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.17.5 Blue Sail Medical Recent Developments/Updates
  • 2.18 Shanghai Bio-heart Biological Technology
    • 2.18.1 Shanghai Bio-heart Biological Technology Details
    • 2.18.2 Shanghai Bio-heart Biological Technology Major Business
    • 2.18.3 Shanghai Bio-heart Biological Technology Drug Coated Stent System Product and Services
    • 2.18.4 Shanghai Bio-heart Biological Technology Drug Coated Stent System Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.18.5 Shanghai Bio-heart Biological Technology Recent Developments/Updates

3 Competitive Environment: Drug Coated Stent System by Manufacturer

  • 3.1 Global Drug Coated Stent System Sales Quantity by Manufacturer (2020-2025)
  • 3.2 Global Drug Coated Stent System Revenue by Manufacturer (2020-2025)
  • 3.3 Global Drug Coated Stent System Average Price by Manufacturer (2020-2025)
  • 3.4 Market Share Analysis (2024)
    • 3.4.1 Producer Shipments of Drug Coated Stent System by Manufacturer Revenue ($MM) and Market Share (%): 2024
    • 3.4.2 Top 3 Drug Coated Stent System Manufacturer Market Share in 2024
    • 3.4.3 Top 6 Drug Coated Stent System Manufacturer Market Share in 2024
  • 3.5 Drug Coated Stent System Market: Overall Company Footprint Analysis
    • 3.5.1 Drug Coated Stent System Market: Region Footprint
    • 3.5.2 Drug Coated Stent System Market: Company Product Type Footprint
    • 3.5.3 Drug Coated Stent System Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Drug Coated Stent System Market Size by Region
    • 4.1.1 Global Drug Coated Stent System Sales Quantity by Region (2020-2031)
    • 4.1.2 Global Drug Coated Stent System Consumption Value by Region (2020-2031)
    • 4.1.3 Global Drug Coated Stent System Average Price by Region (2020-2031)
  • 4.2 North America Drug Coated Stent System Consumption Value (2020-2031)
  • 4.3 Europe Drug Coated Stent System Consumption Value (2020-2031)
  • 4.4 Asia-Pacific Drug Coated Stent System Consumption Value (2020-2031)
  • 4.5 South America Drug Coated Stent System Consumption Value (2020-2031)
  • 4.6 Middle East & Africa Drug Coated Stent System Consumption Value (2020-2031)

5 Market Segment by Type

  • 5.1 Global Drug Coated Stent System Sales Quantity by Type (2020-2031)
  • 5.2 Global Drug Coated Stent System Consumption Value by Type (2020-2031)
  • 5.3 Global Drug Coated Stent System Average Price by Type (2020-2031)

6 Market Segment by Application

  • 6.1 Global Drug Coated Stent System Sales Quantity by Application (2020-2031)
  • 6.2 Global Drug Coated Stent System Consumption Value by Application (2020-2031)
  • 6.3 Global Drug Coated Stent System Average Price by Application (2020-2031)

7 North America

  • 7.1 North America Drug Coated Stent System Sales Quantity by Type (2020-2031)
  • 7.2 North America Drug Coated Stent System Sales Quantity by Application (2020-2031)
  • 7.3 North America Drug Coated Stent System Market Size by Country
    • 7.3.1 North America Drug Coated Stent System Sales Quantity by Country (2020-2031)
    • 7.3.2 North America Drug Coated Stent System Consumption Value by Country (2020-2031)
    • 7.3.3 United States Market Size and Forecast (2020-2031)
    • 7.3.4 Canada Market Size and Forecast (2020-2031)
    • 7.3.5 Mexico Market Size and Forecast (2020-2031)

8 Europe

  • 8.1 Europe Drug Coated Stent System Sales Quantity by Type (2020-2031)
  • 8.2 Europe Drug Coated Stent System Sales Quantity by Application (2020-2031)
  • 8.3 Europe Drug Coated Stent System Market Size by Country
    • 8.3.1 Europe Drug Coated Stent System Sales Quantity by Country (2020-2031)
    • 8.3.2 Europe Drug Coated Stent System Consumption Value by Country (2020-2031)
    • 8.3.3 Germany Market Size and Forecast (2020-2031)
    • 8.3.4 France Market Size and Forecast (2020-2031)
    • 8.3.5 United Kingdom Market Size and Forecast (2020-2031)
    • 8.3.6 Russia Market Size and Forecast (2020-2031)
    • 8.3.7 Italy Market Size and Forecast (2020-2031)

9 Asia-Pacific

  • 9.1 Asia-Pacific Drug Coated Stent System Sales Quantity by Type (2020-2031)
  • 9.2 Asia-Pacific Drug Coated Stent System Sales Quantity by Application (2020-2031)
  • 9.3 Asia-Pacific Drug Coated Stent System Market Size by Region
    • 9.3.1 Asia-Pacific Drug Coated Stent System Sales Quantity by Region (2020-2031)
    • 9.3.2 Asia-Pacific Drug Coated Stent System Consumption Value by Region (2020-2031)
    • 9.3.3 China Market Size and Forecast (2020-2031)
    • 9.3.4 Japan Market Size and Forecast (2020-2031)
    • 9.3.5 South Korea Market Size and Forecast (2020-2031)
    • 9.3.6 India Market Size and Forecast (2020-2031)
    • 9.3.7 Southeast Asia Market Size and Forecast (2020-2031)
    • 9.3.8 Australia Market Size and Forecast (2020-2031)

10 South America

  • 10.1 South America Drug Coated Stent System Sales Quantity by Type (2020-2031)
  • 10.2 South America Drug Coated Stent System Sales Quantity by Application (2020-2031)
  • 10.3 South America Drug Coated Stent System Market Size by Country
    • 10.3.1 South America Drug Coated Stent System Sales Quantity by Country (2020-2031)
    • 10.3.2 South America Drug Coated Stent System Consumption Value by Country (2020-2031)
    • 10.3.3 Brazil Market Size and Forecast (2020-2031)
    • 10.3.4 Argentina Market Size and Forecast (2020-2031)

11 Middle East & Africa

  • 11.1 Middle East & Africa Drug Coated Stent System Sales Quantity by Type (2020-2031)
  • 11.2 Middle East & Africa Drug Coated Stent System Sales Quantity by Application (2020-2031)
  • 11.3 Middle East & Africa Drug Coated Stent System Market Size by Country
    • 11.3.1 Middle East & Africa Drug Coated Stent System Sales Quantity by Country (2020-2031)
    • 11.3.2 Middle East & Africa Drug Coated Stent System Consumption Value by Country (2020-2031)
    • 11.3.3 Turkey Market Size and Forecast (2020-2031)
    • 11.3.4 Egypt Market Size and Forecast (2020-2031)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2020-2031)
    • 11.3.6 South Africa Market Size and Forecast (2020-2031)

12 Market Dynamics

  • 12.1 Drug Coated Stent System Market Drivers
  • 12.2 Drug Coated Stent System Market Restraints
  • 12.3 Drug Coated Stent System Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Drug Coated Stent System and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Drug Coated Stent System
  • 13.3 Drug Coated Stent System Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Drug Coated Stent System Typical Distributors
  • 14.3 Drug Coated Stent System Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Drug Coated Stent System market size was valued at US$ million in 2024 and is forecast to a readjusted size of USD million by 2031 with a CAGR of %during review period.
    In this report, we will assess the current U.S. tariff framework alongside international policy adaptations, analyzing their effects on competitive market structures, regional economic dynamics, and supply chain resilience.
    Drug coated stent system is a medical device used for treating cardiovascular diseases. It combines metal stent and drug coating technology, aiming to prevent the recurrence and restenosis of arterial stenosis or occlusion. Drug coatings can be released into the surrounding tissues of blood vessel walls, inhibiting the proliferation of neovascular endothelial cells and reducing the risk of restenosis.
    This report is a detailed and comprehensive analysis for global Drug Coated Stent System market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
    Key Features:
    Global Drug Coated Stent System market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
    Global Drug Coated Stent System market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
    Global Drug Coated Stent System market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
    Global Drug Coated Stent System market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2020-2025
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Drug Coated Stent System
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Drug Coated Stent System market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include QualiMe, Medtronic, Cardionovum, MicroPort, P+F Products + Features GmbH, Boston Scientific, Abbott, Biotronik, USM Healthcare, Concept Medical Inc, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market Segmentation
    Drug Coated Stent System market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    Rapamycin Coated Stent
    Ivimox Coated Bracket
    Paclitaxel Coated Stent
    Zothamos Coated Bracket
    Market segment by Application
    Hospital
    Clinic
    Others
    Major players covered
    QualiMe
    Medtronic
    Cardionovum
    MicroPort
    P+F Products + Features GmbH
    Boston Scientific
    Abbott
    Biotronik
    USM Healthcare
    Concept Medical Inc
    MicroPort Scientific Corporation
    Lepu Medical Technology
    JW Medical Systems
    SINOMED
    Kinhely Bio-Tech
    Shandong Huaan Biotechnology
    Blue Sail Medical
    Shanghai Bio-heart Biological Technology
    Market segment by region, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 15 chapters:
    Chapter 1, to describe Drug Coated Stent System product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top manufacturers of Drug Coated Stent System, with price, sales quantity, revenue, and global market share of Drug Coated Stent System from 2020 to 2025.
    Chapter 3, the Drug Coated Stent System competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
    Chapter 4, the Drug Coated Stent System breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
    Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
    Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Drug Coated Stent System market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
    Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
    Chapter 13, the key raw materials and key suppliers, and industry chain of Drug Coated Stent System.
    Chapter 14 and 15, to describe Drug Coated Stent System sales channel, distributors, customers, research findings and conclusion.

    Buy now